Princeton University Office of Technology Licensing & Intellectual Property
4th Floor, New South Building
Post Office Box 36
Princeton, New Jersey 08544-0036
Phone: (609) 258-6762
FAX: (609) 258-1159
Overview
Quorum Sensing is an essential form of intercellular communication used by many types of common bacteria, and many pathogenic bacteria use quorum sensing to attack and invade the human host. Quorum Sensing is used by bacteria to detect a “critical cell number,” which is the cell population required for pathogenic bacteria to release effective amounts of toxins that overcome host immune defenses. In a sparse pathogenic bacteria population, the early release of toxins would stimulate the human immune system to neutralize the bacteria. Pathogenic bacteria have developed an evolutionary strategy whereby they can “sense” when they have amassed a critical cell number before producing virulence factors which enable the bacteria to persist in the human host and to cause the infection.
Researchers at Princeton University have discovered the bacterial gene and molecule necessary for Quorum Sensing. The AI-2 molecule is a signaling molecule produced by some species of bacteria. Each bacterium continually produces AI-2 molecules that flow freely across its cell membrane. In a low cell population, AI-2 molecules are “swept away” by diffusion. In a high cell population, AI-2 molecules begin to flow from one bacterial cell into another where they bind to receptor proteins triggering a biochemical reaction. In the case of pathogenic bacteria in a high cell population, AI-2 molecules bind to LuxP receptor proteins triggering pathogenesis. The LuxS gene is the bacterial gene responsible for producing AI-2 molecules. Hundreds of species of bacteria contain the LuxS gene, including pathogenic bacteria such as Escherichia coli, Salmonella typhimurium, Vibrio cholerae, Staphylococcus aureus, Bacillus anthracis, and Enterococcus faecalis.
The structures of the AI-2 molecule and the LuxP receptor protein have been elucidated by researchers at Princeton University. Inhibitor development obstructing the Quorum Sensing pathway is now possible. It is proposed that analogues of AI-2 be developed to bind to the LuxP receptor protein, in effect, blocking the binding of AI-2 and preventing its subsequent triggering of pathogenesis. This therapeutic compound would be a new type of “antibiotic” that would disrupt pathogenic bacteria communication and, therefore, prevent pathogenesis. It is anticipated that this new class of antibiotics would not be subject to the classic mechanism of increasing bacterial resistance to common antibiotics, which is a current problem in medical treatment of bacterial infections.
US # 6,720,415 Compositions and methods for regulating bacterial pathogenesis
US # 6,559,176 Compounds and methods for regulating bacterial growth and pathogenesis
Patents Pending:
US Patent application # 09/853,257 LUXO-54 Interactions and Methods of Use
US Patent application # 09/961,452 Compositions and Methods Regulating Bacterial
Growth and Pathogenesis
US Patent application # 09/961,453 Compositions and Methods Regulating Bacterial
Growth and Pathogenesis
US Patent application # 09/961,458 Compositions and Methods Regulating Bacterial
Growth and Pathogenesis
US Patent application # 10/300,818 Compounds and Methods for Regulating Bacterial
Growth and Pathogenesis
US Patent application # 10/387,345 Compositions and Methods for Regulating Bacterial
Pathogenesis
US Patent application # 10/227,400 Crystals of LuxP and Complexes Thereof
US Patent application # 10/409,783 Compositions and Methods for Regulating Bacterial
Pathogenesis
US Patent application # 10/802,425 Compositions and Methods for Regulating Bacterial
Pathogenesis
US Patent application # 09/961,637 Compositions and Methods for Regulating Bacterial
Pathogenesis
US Patent application # 09/961,507 Compositions and Methods for Regulating Bacterial
Pathogenesis